Fused pyrimidine derivatives for inhibition of tyrosine kinase activity
USRE46511E1 · kind E1 · reissue
1Cited by
1References
54Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 2016 |
| Grant date | Aug 15, 2017 |
| Priority date | — |
| Expiry date | Apr 14, 2036 |
Classification
- Technology area (CPC —)General
Abstract
The present invention relates to a novel fused pyrimidine derivative having an inhibitory activity for tyrosine kinases, and a pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases comprising same as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.